Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2697 |
|
| Actual shortage: | 241 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2447 (91%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-03-28 | 2024-06-13 | 223853 |
| TEVA-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-11-03 | 2024-06-13 | 209148 |
| TEVA-ENTACAPONE | 200MG | TABLET | Actual shortage | 2024-05-30 | 2024-06-13 | 229227 |
| TEVA-TELMISARTAN HCTZ | 25.0MG 80.0MG | TABLET | Actual shortage | 2024-04-11 | 2024-06-13 | 224901 |
| TEVA-TOBRAMYCIN | 60MG | SOLUTION | Actual shortage | 2024-05-09 | 2024-06-13 | 227495 |
| TEVA-CINACALCET | 30MG | TABLET | Actual shortage | 2024-04-11 | 2024-06-13 | 224907 |
| TEVA-CINACALCET | 60MG | TABLET | Actual shortage | 2024-04-11 | 2024-06-13 | 224910 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Actual shortage | 2024-06-13 | 2024-06-13 | 230316 |
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Actual shortage | 2024-06-13 | 2024-06-13 | 230320 |
| TEVA-NAPROXEN | 500MG | TABLET | Resolved | 2024-05-16 | 2024-06-13 | 228140 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Resolved | 2024-04-05 | 2024-06-13 | 224448 |
| TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-12-14 | 2024-06-13 | 213368 |
| TEVA-IPRATROPIUM STERINEBS | 250MCG | SOLUTION | Resolved | 2023-10-19 | 2024-06-13 | 207512 |
| TEVA-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-18 | 2024-06-13 | 222572 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 10MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Actual shortage | 2022-08-18 | 2024-06-13 | 166969 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-13 | 166972 |
| OCTREOTIDE FOR INJECTABLE SUSPENSION | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT | Resolved | 2022-08-18 | 2024-06-13 | 166975 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |